Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Abatacept for ICI-Induced Myocarditis
NCT05195645Phase 2Completed
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Oct 2022
- Primary completion
- Mar 2024
- Modality
- Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 2 trial of abatacept in myocarditis, sponsored by Assistance publique - Hôpitaux de Paris. Started Oct 2022; status: completed.
02
Drugs
abatacept
03
Conditions
myocarditis
Beyond the preview
Go deeper on NCT05195645.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05195645.